We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SE:NYSESea Limited Analysis

Data as of 2026-04-30 - not real-time

$83.21

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Sea Limited (SE) is trading well below its 20‑day and 50‑day moving averages, with the price sitting beneath the 200‑day SMA, signaling a pronounced bearish technical backdrop. The RSI sits in the low‑40s, suggesting neutral‑to‑slightly bearish momentum, while the MACD histogram has turned positive, offering a modest bullish signal that may precede a short‑term bounce. Volatility remains elevated at over 40% on a 30‑day basis and beta exceeds 1.4, underscoring heightened price swings relative to the market.
Fundamentally, SE delivers robust top‑line growth (~38% YoY) and solid margins, with operating cash flow exceeding $5 bn and free cash flow turning positive. However, the DCF fair‑value estimate of roughly $42 per share is half the current market price, implying the stock is considerably overvalued. Recent material news highlights an AI Centre of Excellence launch in Singapore and continued insider buying, while high‑profile investors such as Steve Cohen maintain long‑term stakes, indicating confidence in the company’s strategic direction despite near‑term price pressure.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below short‑term moving averages and near support level
  • Elevated volatility and beta increasing downside risk
  • Positive MACD histogram may limit further decline

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue growth and improving cash conversion
  • Strategic AI investments expanding digital ecosystem
  • Analyst consensus of strong‑buy and upside potential despite current price

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Dominant position in Southeast Asian e‑commerce and digital entertainment
  • Diversified financial services platform offering higher margin upside
  • Long‑term investor confidence from institutions like Steve Cohen’s fund

Key Metrics & Analysis

Financial Health

Revenue Growth38.40%
Profit Margin6.88%
P/E Ratio33.0
ROE15.25%
ROA4.77%
Debt/Equity26.69
P/B Ratio4.1
Op. Cash Flow$5.0B
Free Cash Flow$511.0M

Technical Analysis

TrendBearish
RSI42.0
Support$79.00
Resistance$93.44
MA 20$85.73
MA 50$89.71
MA 200$136.74
MACDBullish
VolumeIncreasing
Fear & Greed Index88.27

Valuation

Fair Value$42.41
Target Price$137.64
Upside/Downside65.41%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta1.45
Volatility42.96%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.